Adherence

Texting Eliminates 70% of Emergency Department Discharge Phone Calls

Retrieved on: 
Tuesday, May 18, 2021
Health sciences, Health, Online chat, Text messaging, Adherence

Assuming an average call takes 2 minutes, emergency department discharge text messaging saved MMC more than 500 staff hours in 2020.\nMMC determined that its staff was spending significant time making follow-up phone calls to emergency department-discharged patients, with many calls leading to voicemails.

Key Points: 
  • Assuming an average call takes 2 minutes, emergency department discharge text messaging saved MMC more than 500 staff hours in 2020.\nMMC determined that its staff was spending significant time making follow-up phone calls to emergency department-discharged patients, with many calls leading to voicemails.
  • Texting also allowing us to achieve other improvements, such as increasing adherence with primary care follow-up appointments and collections.
  • Phone calls require substantial staff time and resources but deliver poor results because of the tendency for consumers to ignore calls from unfamiliar numbers.
  • Two-way texting is a convenient, fast, effective, and affordable communication resource for stakeholder engagement.

Navitus Health Solutions Earns 2021 Pharmacy Quality Alliance Award for High Achievement in Medication Quality Measures

Retrieved on: 
Tuesday, May 18, 2021
General Health, Diabetes, Health, Pharmaceutical, Managed care, Health sciences, Health, Clinical pharmacology, Pharmacy, Symbols, Medical terminology, Pharmaceuticals policy, Pharmacy benefit management, Adherence, Prescription drug, Medicare, Medical prescription

b'Navitus Health Solutions, a full pass-through pharmacy benefit manager (PBM), today announced that it received the 2021 Pharmacy Quality Alliance (PQA) Laura Cranston Excellence in Quality Award for its prescription drug plan (PDP), Navitus MedicareRx.

Key Points: 
  • b'Navitus Health Solutions, a full pass-through pharmacy benefit manager (PBM), today announced that it received the 2021 Pharmacy Quality Alliance (PQA) Laura Cranston Excellence in Quality Award for its prescription drug plan (PDP), Navitus MedicareRx.
  • Navitus is one of nine healthcare organizations to receive PQA\xe2\x80\x99s Excellence in Quality Award for PDPs this year.
  • However, medication non-adherence is a longstanding issue in the United States.
  • As such, Navitus is committed to taking the unnecessary costs out of pharmacy benefits to make prescriptions more affordable for hundreds of plan sponsors (i.e., employers, health plans, unions, government programs, etc.)

epocrates and ConnectiveRx Announce Exclusive Reseller Partnership to Help More Patients Overcome Medication Cost Barriers with ScriptGuide Patient Savings Messages

Retrieved on: 
Thursday, May 13, 2021
Software, Biotechnology, Pharmaceutical, General Health, Health, Data management, Technology, Mobile, Wireless, Health sciences, Health, Pharmacy, Medical terminology, Health care quality, Clinical pharmacology, Adherence

epocrates and ConnectiveRx will help pharmaceutical brands broaden awareness among clinicians and their patients about medication savings offers via ScriptGuide messages.

Key Points: 
  • epocrates and ConnectiveRx will help pharmaceutical brands broaden awareness among clinicians and their patients about medication savings offers via ScriptGuide messages.
  • ScriptGuide messages are distributed to clinicians in workflow through the expansive ConnectiveRx EHR Networks and are designed to increase patient awareness of medication savings offers where they are most impactful \xe2\x80\x93 at the point of care.
  • We are thrilled to become the exclusive reseller of ConnectiveRx\xe2\x80\x99s ScriptGuide coupons to break down barriers to medication access and adherence,\xe2\x80\x9d said Diane Bartoli, vice president and general manager, epocrates.
  • For more information, please visit: www.epocrates.com .\nConnectiveRx works hard to help take the pain out of the prescription process for pharmaceutical manufacturers, healthcare providers and their patients.

RxCap Partners with Centor, a Gerresheimer Company, to Provide Prescription Medication Compliance SmartCaps to Pharmacies

Retrieved on: 
Thursday, May 13, 2021
Health sciences, Health, Pharmacy, Symbols, Clinical pharmacology, Medical terminology, Medicinal chemistry, Pharmacist, Adherence, Medical prescription

Pharmacists can now more accurately monitor critical care clients remotely through their prescription compliance.\n"Prior to the RxCap solution, pharmacists were solely dependent on the patient\'s self-reporting to track medication adherence.

Key Points: 
  • Pharmacists can now more accurately monitor critical care clients remotely through their prescription compliance.\n"Prior to the RxCap solution, pharmacists were solely dependent on the patient\'s self-reporting to track medication adherence.
  • The RxCap products and platform are groundbreaking for pharmacists and patients to help achieve better outcomes" said Patrick O\'Connell, Vice President of Centor.
  • All Centor sales reps now have the RxCap SmartCap to demo and provide to Pharmacies for trial usage with patients with the 1-Clic vial.
  • Gerresheimer has worldwide operations and over 11,000 employees.\nCentor is the world\'s largest supplier of regulatory compliant prescription containers for medication dispensing.

Loopback Analytics and Infirmary Health Partner on Specialty Pharmacy to Improve Patient Outcomes

Retrieved on: 
Tuesday, May 11, 2021
Health sciences, Articles, Health, Pharmacy, Specialty drugs, Health care quality, Business intelligence, Formal sciences, Adherence, Analytics, Specialty pharmacy

b'DALLAS, May 11, 2021 /PRNewswire/ -- Loopback Analytics, a leader in population health analytics, is excited to announce its partnership with Infirmary Health to continue advancing specialty pharmacy initiatives.\nSpecialty pharmacy is a rapidly evolving, innovative area, and health systems like Infirmary Healtha URAC and ACHC-accredited organizationplay a key role in ensuring patients get timely access to the medications they need.

Key Points: 
  • b'DALLAS, May 11, 2021 /PRNewswire/ -- Loopback Analytics, a leader in population health analytics, is excited to announce its partnership with Infirmary Health to continue advancing specialty pharmacy initiatives.\nSpecialty pharmacy is a rapidly evolving, innovative area, and health systems like Infirmary Healtha URAC and ACHC-accredited organizationplay a key role in ensuring patients get timely access to the medications they need.
  • "We\'re excited to work alongside Loopback Analytics to utilize data in our efforts to improve outcomes and increase patient satisfaction.
  • "\nThrough its partnership with Loopback Analytics, Infirmary Health aims to increase patient access to specialty medication and improve medication adherence.
  • Using Loopback Analytics\' portfolio of pharmacy solutions, Infirmary Health can more effectively identify and manage at-risk patients while improving clinical outcomes related to specialty medications.\n"Through this new partnership, Loopback will be providing Infirmary Health with advanced analytics to grow their pharmacy business and improve timely access to the specialty medications patients need," said Neil Smiley, CEO, Loopback Analytics.

Excelera to Present Poster on Tuberculosis Screening Compliance at PQA Annual Meeting

Retrieved on: 
Tuesday, May 11, 2021
Health sciences, Health, Pharmacy, Health in Africa, Tuberculosis, Pharmacist, Adherence, PQA

b'MINNEAPOLIS, May 11, 2021 /PRNewswire/ -- Excelera , a subsidiary of Shields Health Solutions and the company behind the Excelera Network, announced today that it will present a poster on tuberculosis (TB) screening compliance and the value of pharmacist interventions in supporting safe medication use at the Pharmacy Quality Alliance (PQA) Annual Meeting .

Key Points: 
  • b'MINNEAPOLIS, May 11, 2021 /PRNewswire/ -- Excelera , a subsidiary of Shields Health Solutions and the company behind the Excelera Network, announced today that it will present a poster on tuberculosis (TB) screening compliance and the value of pharmacist interventions in supporting safe medication use at the Pharmacy Quality Alliance (PQA) Annual Meeting .
  • Titled "Compliance to Recommended Tuberculosis Screening Prior to Initiating Biologic Treatment Across a Network of Health-System Specialty Pharmacies," the poster is the first known quality initiative report analyzing tuberculosis testing compliance in patients starting biologic therapy across multiple health system specialty pharmacies.
  • Lana Gerzenshtein, PharmD, BCPS, CSP and Zach Russell, PharmD, CSP from Excelera are the lead authors of the poster.\nThe PQA Annual Meeting poster session features professionals from across PQA\'s membership presenting innovative research surrounding medication use quality.
  • Attendees can view the posters in PDF format throughout the Annual Meeting via the online meeting platform.

emocha Health Wins 2021 MedTech Breakthrough Award

Retrieved on: 
Thursday, May 6, 2021
Medical terminology, Health sciences, Health, Medicine, Adherence, mHealth, Medtech, Chronic condition, Zimmer Biomet Robotics

b'BALTIMORE, May 6, 2021 /PRNewswire/ -- emocha Health , the leading digital medication adherence program, today announced that it has been selected as the winner of the "Best New Technology Solution for Medication Management"award in the fifth annual MedTech Breakthrough Awards program.

Key Points: 
  • b'BALTIMORE, May 6, 2021 /PRNewswire/ -- emocha Health , the leading digital medication adherence program, today announced that it has been selected as the winner of the "Best New Technology Solution for Medication Management"award in the fifth annual MedTech Breakthrough Awards program.
  • This year\'s program attracted more than 3,850 nominations from over 17 countries.\n"This award from MedTech Breakthrough means a great deal to all of us at team emocha," said Sebastian Seiguer, CEO of emocha.
  • emocha partners with health plans, health systems, employers and health departments across the country to radically improve adherence for patients with diabetes, asthma, tuberculosis, and other chronic and infectious diseases.
  • The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough health and medical companies and products in categories that include Patient Engagement, mHealth, Health & Fitness, Clinical Administration, Healthcare IoT, Medical Data, Healthcare Cybersecurity and more.

AdhereHealth Releases Next-Generation Resolve Offering to Improve Member Experience for CAHPS and HOS Surveys

Retrieved on: 
Thursday, May 6, 2021
Health, Health care quality, Pharmacy, Health informatics, Consumer Assessment of Healthcare Providers and Systems, Patient advocacy, Telepharmacy, Customer relationship management, Adherence

b'NASHVILLE, Tenn., May 6, 2021 /PRNewswire/ -- AdhereHealth , a healthcare technology leader in medication adherence insights and health outcomes, today announced the release ofnew member experience capabilities to improve Medicare Advantage (MA) Star Ratings health plan satisfaction through its next-generation Resolve offering.

Key Points: 
  • b'NASHVILLE, Tenn., May 6, 2021 /PRNewswire/ -- AdhereHealth , a healthcare technology leader in medication adherence insights and health outcomes, today announced the release ofnew member experience capabilities to improve Medicare Advantage (MA) Star Ratings health plan satisfaction through its next-generation Resolve offering.
  • Through the foundational customer relationship management (CRM) toolset and rich data visualizations, Resolve addresses CAHPS and HOS issues, illustrating year-round population-level and unique member status for each respective survey measure at risk.\n"We believe missing information and misinformation are at the core of member experience issues.
  • These problems can be squarely addressed by the right combination of technology and telepharmacy outreach," said Jason Z.
  • "Our Resolve solution uses proprietary analytics, clinical workflow, available health plan benefits and local community social service software integration to overcome CAHPS-related member experience issues that impact Star Ratings due to poor satisfaction.

Protenus' 5th Annual PANDAS Conference Cultivates Innovation and Compliance Best Practices Throughout COVID-19 Pandemic

Retrieved on: 
Wednesday, May 5, 2021
Health, Health informatics, Medical terminology, Pharmacy, Digital health, Telehealth, Medical privacy, Adherence

She will also discuss from her vantage point, three opportunities where technology can make an impact on healthcare and what is necessary to enable success.

Key Points: 
  • She will also discuss from her vantage point, three opportunities where technology can make an impact on healthcare and what is necessary to enable success.
  • Compliance analytics provide healthcare leaders full insight into how health data is being used, and alerts privacy, pharmacy and compliance teams to inappropriate activity.
  • Protenus helps our partner hospitals make decisions about how to better protect their data, their patients, and their institutions.
  • For two consecutive years, Protenus was named one of Forbes\' Best Startup Employers and one of CBInsights Digital Health 150.

Yangtze River Pharmaceutical Group Selects TraceLink Platform for Global Compliance

Retrieved on: 
Wednesday, May 5, 2021
Rivers of China, Health sciences, Health, Pharmacy, Adherence, Clinical pharmacology, Health care quality, Medical terminology, Dahod, Yangtze

b'NORTH READING,Mass., May 5, 2021 /PRNewswire/ -- TraceLink Inc., the leading digital network platform company, today announced that Yangtze River Pharmaceutical Group has selected TraceLink\'s global compliance solution to aid its plans for global growth.

Key Points: 
  • b'NORTH READING,Mass., May 5, 2021 /PRNewswire/ -- TraceLink Inc., the leading digital network platform company, today announced that Yangtze River Pharmaceutical Group has selected TraceLink\'s global compliance solution to aid its plans for global growth.
  • "Given the broad scope of our portfolio and diverse business model, TraceLink\' s integrated network, global compliance solutions and low total cost of ownership are crucial for us to achieve commercial success in multiple markets.
  • "\n"Global commercialization has become a top priority during this special milestone year for YRPG and serialization compliance is a necessary step in their preparation for global expansion," said Shabbir Dahod, President and CEO, TraceLink.
  • Yangtze River Pharmaceutical Group\'s products include Chinese, Western medicines andAPIs, covering ten fields, nearly 20 dosage forms and over 300typesofmedicines and strengths.